1. Home
  2. RPRX vs PFGC Comparison

RPRX vs PFGC Comparison

Compare RPRX & PFGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RPRX
  • PFGC
  • Stock Information
  • Founded
  • RPRX 1996
  • PFGC 1885
  • Country
  • RPRX United States
  • PFGC United States
  • Employees
  • RPRX N/A
  • PFGC N/A
  • Industry
  • RPRX Biotechnology: Pharmaceutical Preparations
  • PFGC Food Distributors
  • Sector
  • RPRX Health Care
  • PFGC Consumer Discretionary
  • Exchange
  • RPRX Nasdaq
  • PFGC Nasdaq
  • Market Cap
  • RPRX 16.2B
  • PFGC 14.8B
  • IPO Year
  • RPRX 2020
  • PFGC 2015
  • Fundamental
  • Price
  • RPRX $39.71
  • PFGC $96.78
  • Analyst Decision
  • RPRX Strong Buy
  • PFGC Strong Buy
  • Analyst Count
  • RPRX 3
  • PFGC 9
  • Target Price
  • RPRX $46.00
  • PFGC $116.78
  • AVG Volume (30 Days)
  • RPRX 4.5M
  • PFGC 1.4M
  • Earning Date
  • RPRX 11-05-2025
  • PFGC 11-05-2025
  • Dividend Yield
  • RPRX 2.21%
  • PFGC N/A
  • EPS Growth
  • RPRX N/A
  • PFGC N/A
  • EPS
  • RPRX 1.75
  • PFGC 2.09
  • Revenue
  • RPRX $2,349,844,000.00
  • PFGC $61,559,300,000.00
  • Revenue This Year
  • RPRX $36.16
  • PFGC $14.64
  • Revenue Next Year
  • RPRX $2.04
  • PFGC $6.34
  • P/E Ratio
  • RPRX $22.74
  • PFGC $45.99
  • Revenue Growth
  • RPRX 3.70
  • PFGC 11.61
  • 52 Week Low
  • RPRX $24.05
  • PFGC $68.40
  • 52 Week High
  • RPRX $41.24
  • PFGC $109.05
  • Technical
  • Relative Strength Index (RSI)
  • RPRX 59.32
  • PFGC 48.82
  • Support Level
  • RPRX $37.31
  • PFGC $91.84
  • Resistance Level
  • RPRX $40.00
  • PFGC $97.46
  • Average True Range (ATR)
  • RPRX 1.03
  • PFGC 2.53
  • MACD
  • RPRX -0.03
  • PFGC 0.28
  • Stochastic Oscillator
  • RPRX 85.66
  • PFGC 53.10

About RPRX Royalty Pharma plc

Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.

About PFGC Performance Food Group Company

Performance Food Group Co , markets and distributes national and company-branded food and food-related products. The company also specializes in distributing candy, snacks, beverages, cigarettes, other tobacco products, health and beauty care products and other items to vending distributors, box retailers, theaters, convenience stores, drug stores, grocery stores, travel providers, and hospitality providers. The company has three reportable segments: Foodservice, Vistar, and Convenience.

Share on Social Networks: